149 related articles for article (PubMed ID: 12604545)
1. Use of the microbial growth curve in postantibiotic effect studies of Legionella pneumophila.
Smith RP; Baltch AL; Michelsen PB; Ritz WJ; Alteri R
Antimicrob Agents Chemother; 2003 Mar; 47(3):1081-7. PubMed ID: 12604545
[TBL] [Abstract][Full Text] [Related]
2. Postantibiotic effect of various antibiotics on Legionella pneumophila strains isolated from water systems.
Birteksöz-Tan AS; Zeybek Z
Folia Microbiol (Praha); 2012 Nov; 57(6):495-9. PubMed ID: 22627604
[TBL] [Abstract][Full Text] [Related]
3. In vitro and intracellular activities of LBM415 (NVP PDF-713) against Legionella pneumophila.
Edelstein PH; Hu B; Edelstein MA
Antimicrob Agents Chemother; 2005 Jun; 49(6):2533-5. PubMed ID: 15917565
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic Resistance and Azithromycin Resistance Mechanism of Legionella pneumophila Serogroup 1 in China.
Jia X; Ren H; Nie X; Li Y; Li J; Qin T
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405864
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic susceptibility of Legionella pneumophila strains isolated in England and Wales 2007-17.
Wilson RE; Hill RLR; Chalker VJ; Mentasti M; Ready D
J Antimicrob Chemother; 2018 Oct; 73(10):2757-2761. PubMed ID: 30053025
[TBL] [Abstract][Full Text] [Related]
6. Minimum inhibitory concentration (MIC) distribution among wild-type strains of Legionella pneumophila identifies a subpopulation with reduced susceptibility to macrolides owing to efflux pump genes.
Vandewalle-Capo M; Massip C; Descours G; Charavit J; Chastang J; Billy PA; Boisset S; Lina G; Gilbert C; Maurin M; Jarraud S; Ginevra C
Int J Antimicrob Agents; 2017 Nov; 50(5):684-689. PubMed ID: 28782709
[TBL] [Abstract][Full Text] [Related]
7. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.
Baltch AL; Smith RP; Ritz W
Antimicrob Agents Chemother; 1995 Aug; 39(8):1661-6. PubMed ID: 7486896
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of macrolides against intracellular Legionella pneumophila.
Segreti J; Meyer P; Kapell K
Diagn Microbiol Infect Dis; 1996 Jul; 25(3):123-6. PubMed ID: 8902407
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of six intracellular antibiotics against Legionella pneumophila strains of human and environmental origin.
Reda C; Quaresima T; Pastoris MC
J Antimicrob Chemother; 1994 Apr; 33(4):757-64. PubMed ID: 8056694
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia.
Edelstein PH; Shinzato T; Doyle E; Edelstein MA
Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675
[TBL] [Abstract][Full Text] [Related]
12. Correlation of MIC value and disk inhibition zone diameters in clinical Legionella pneumophila serogroup 1 isolates.
Bruin JP; Diederen BM; Ijzerman EP; Den Boer JW; Mouton JW
Diagn Microbiol Infect Dis; 2013 Jul; 76(3):339-42. PubMed ID: 23583350
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
Dubois J; St-Pierre C
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic sensitivity of environmental Legionella pneumophila strains isolated in Poland.
Gładysz I; Sikora A; Wójtowicz-Bobin M; Szepeluk A; Matuszewska R; Bartosik M; Karczewski JK
Ann Agric Environ Med; 2023 Dec; 30(4):602-605. PubMed ID: 38153060
[TBL] [Abstract][Full Text] [Related]
15. Wild-type MIC distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates.
Bruin JP; Ijzerman EP; den Boer JW; Mouton JW; Diederen BM
Diagn Microbiol Infect Dis; 2012 Jan; 72(1):103-8. PubMed ID: 22100012
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of antimicrobial agents against Legionella isolated from environmental water systems: first results from Turkey.
Erdogan H; Can F; Demirbilek M; Timurkaynak F; Arslan H
Environ Monit Assess; 2010 Dec; 171(1-4):487-91. PubMed ID: 20049525
[TBL] [Abstract][Full Text] [Related]
17. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs.
Edelstein PH; Shinzato T; Edelstein MA
J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic efficacy of levofloxacin against a model of replicable Legionella pneumophila lung infection in DBA/2 mice].
Kashimoto Y; Kurosaka Y; Karibe Y; Uoyama S; Fujikawa K; Namba K; Otani T; Yamaguchi K
Jpn J Antibiot; 2009 Oct; 62(5):452-9. PubMed ID: 20055122
[TBL] [Abstract][Full Text] [Related]
19. Isolation of ciprofloxacin-resistant Legionella pneumophila in a patient with severe pneumonia.
Bruin JP; Koshkolda T; IJzerman EP; Lück C; Diederen BM; Den Boer JW; Mouton JW
J Antimicrob Chemother; 2014 Oct; 69(10):2869-71. PubMed ID: 24898020
[No Abstract] [Full Text] [Related]
20. The activity of antibiotics against Legionella pneumophila: in vitro and in vivo studies.
Mizen L
J Antimicrob Chemother; 2001 Mar; 47(3):359-60. PubMed ID: 11222573
[No Abstract] [Full Text] [Related]
[Next] [New Search]
